Amin Pharmaceutical Company

Company Intelligence ProfileListed on Tehran Stock Exchange

Amin Pharmaceutical Company

Amin Pharmaceutical Company is a listed pharmaceutical manufacturer headquartered in Isfahan Province. In the Hormuz Group company graph, it matters because it links central Iran's manufacturing base with medicine production, pharmacy distribution, therapeutic staples, regulatory pricing, and imported pharmaceutical inputs. Its listed status makes it useful for monitoring pharmaceutical disclosure, margins, working capital, raw-material exposure, and demand stability in regulated healthcare categories.

ListingListed on Tehran Stock Exchange
ExportLow
VerificationBasic
ConfidenceHigh
Updated28/06/2026
Operating Layer

Products & Services

Amin Pharmaceutical Company manufactures pharmaceutical preparations, including solid, semi-solid, and liquid dosage forms for common therapeutic categories. Its operations support pharmacy supply, hospital demand, domestic drug manufacturing, contract or licensed production, raw-material import substitution, and healthcare-sector distribution from its Isfahan-based industrial platform.

Investor Lens

Investment Relevance

Amin Pharmaceutical is relevant for investors assessing Iran's listed drug-manufacturing sector, domestic healthcare demand, pharmaceutical import substitution, and the operating economics of medicine producers outside Tehran. It can support analysis of raw-material procurement, distributor receivables, product registration, pricing policy, and resilience during medicine shortages. Due diligence should review updated financial statements, product mix, API sourcing, GMP compliance, export channels, ownership, working capital, and exposure to currency or reimbursement delays.

Knowledge Graph

Connected Intelligence

This profile is connected to Hormuz taxonomy layers across geography, industry, market exposure, and investment constraints.

Data Status

Source & Verification Note

Based on public company, official-company, pharmaceutical-sector, market, and disclosure-related information. Further verification is required before treating this profile as verified investment intelligence.